Patents
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
05/2009
05/12/2009US7531560 Anti-cytokine heterocyclic compounds
05/12/2009US7531559 Fungicidal 1,2,3 triazole derivatives
05/12/2009CA2278553C Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulators
05/07/2009WO2009057676A1 Azo compound, and dye-containing polarizing film comprising the same
05/07/2009WO2009056692A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors
05/07/2009WO2009055863A1 Desferrioxamine conjugates, derivatives and analogues
05/07/2009WO2009018065A3 Novel glucokinase activators and methods of using same
05/07/2009US20090118517 Purification process for anastrozole intermediate
05/07/2009CA2703934A1 Azo compound, and dye-containing polarizing film comprising the same
05/07/2009CA2703909A1 P2x3, receptor antagonists for treatment of pain
05/07/2009CA2695628A1 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors
05/06/2009EP2054383A2 Novel compounds as antagonists or inverse agonists at opioid receptors
05/06/2009EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
04/2009
04/30/2009US20090111996 N-(2-aminophenyl)-4-((5,6-dimethoxy-2H-indazol-2-yl)methyl)benzamide, as a solid or liquid formulation adapted for oral administration; antiprolilferative agent
04/30/2009US20090111863 Compounds, Compositions and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies
04/30/2009US20090111862 Compound
04/30/2009US20090111857 1,2,4-triazole ether derivatives as modulators of mglur5
04/30/2009US20090111823 Aminopyridine derivatives as modulators of mglur5
04/30/2009US20090111822 1,2,3-triazole pyrrolidine derivatives as modulators of mglur5
04/30/2009US20090111821 Amino 1,2,4-triazole derivatives as modulators of mglur5
04/30/2009US20090111129 Methods and Kits for Detecting Fungal Infection
04/30/2009US20090106915 Coloring hair non-oxidatively with pyridine dyes complexed with iron (II) ormanganese; 2-(Methyl-[2,2';6'2'']terpyridine-4'yl-amino)-ethanol ligand;no additional dye precursor needed, nor a pretreatment or a swelling agents;simplification
04/29/2009EP2051707A2 Inhibitors of plasma kallikrein
04/29/2009CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity
04/29/2009CN100482666C Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics
04/28/2009US7524875 Polyether with glycerol backbone; capable of being labeled
04/28/2009US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis
04/28/2009US7524863 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
04/28/2009US7524844 Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them
04/28/2009CA2525437C Benzamide inhibitors of the p2x7 receptor
04/23/2009WO2009052078A1 Ccr10 antagonists
04/23/2009WO2007019660A3 Azole compounds used as tuberculostatic and leishmanicide agents
04/23/2009US20090105485 Histone deacetylase inhibitors
04/23/2009US20090105279 Tetrahydrofuro[2,3-b]furyl carbamates containing an (oxy)hydrazide group; these compounds target the HIV protease in both wild type and mutant strains of HIV.
04/23/2009US20090105253 Triazole Derivative and Use Thereof
04/23/2009US20090105230 Anti-inflammatory medicaments
04/23/2009US20090104151 Smac mimetic dimers and trimers useful as anti-cancer agents
04/23/2009CA2702469A1 Ccr10 antagonists
04/22/2009CN101415691A Triazole derivative
04/22/2009CN100481571C Luminescent element material and luminescent element comprising the same
04/21/2009US7521470 Factor Xa inhibitors
04/16/2009WO2009049180A2 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
04/16/2009WO2009047514A1 [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use
04/16/2009WO2009046841A2 Piperidine and piperazine derivatives for treating tumours
04/16/2009WO2007005058A3 Monoazole ligand platinum analogs
04/16/2009WO2003082205A3 Compounds and methods
04/16/2009US20090099233 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
04/16/2009CA2701946A1 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
04/16/2009CA2701519A1 Piperidine and piperazine derivatives
04/15/2009EP2046762A2 Triazolyl phenyl benzenesulfonamides
04/15/2009EP2046733A1 Process for the preparation of epsilon-alkoxycarbonyllysines and their analogues
04/14/2009US7517998 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus
04/14/2009US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase
04/14/2009CA2380980C Mutilin derivatives and their use as antibacterials
04/09/2009WO2009044707A1 Nitrotriazole derivative and method for producing compound using the same
04/09/2009WO2009043117A1 Novel aryl potassium channel blockers and uses thereof
04/09/2009WO2009019472A4 1, 2, 4 -triazole derivatives as serotonergic modulators
04/09/2009WO2008145563A3 Process for preparing triazolones
04/09/2009US20090093524 Compounds and methods for modulating fxr
04/09/2009US20090091234 Room temperature molten salt and display element
04/09/2009CA2701579A1 Novel aryl potassium channel blockers and uses thereof
04/08/2009EP2044018A1 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds
04/08/2009EP1877364B1 Phenylacetylene derivatives having mglur5 receptor affinity
04/08/2009EP1442026B1 Triazole derivatives as cyclooxygenase (cox) inhibitors
04/08/2009CN101405275A Triazolone derivative
04/08/2009CN101402613A Substituted phenoxy oxygen alkylamine triazole alcohol antimycotic compounds and method of preparing the same
04/08/2009CN100475787C Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
04/07/2009US7514475 Benzylamine analogues
04/07/2009US7514459 Gamma-secretase inhibitors
04/07/2009US7514457 Substituted aryloxymethyl bicyclicmethyl acetamide compounds
04/02/2009WO2009021747A3 Treatment of duchenne muscular dystrophy
04/02/2009WO2005057171A3 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds
04/02/2009US20090088570 Organic electroluminescent device
04/02/2009US20090087376 Heterocyclic Dye Compounds For In Vivo Imaging And Diagnosis Of Alzheimer's Disease
04/01/2009EP1646661B1 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drung obtained therefrom
04/01/2009EP1521744B1 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists
04/01/2009CN101400660A Triazole derivative or salt thereof
04/01/2009CN100473648C 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
03/2009
03/31/2009US7511152 6-(trifluoromethyl)-3,9,10,11-tetrahydro-8,10a-methanocyclohepta[1,2]indeno[4,5-d][1,2,3]triazol-7(8H)-one; uterine fibroid disease, hot flashes, urogenital disorders, inflammation; improved metabolic profile
03/31/2009US7511067 3-hydroxymethyl-4-hydroxy-phenyl-derivatives for the treatment of respiratory diseases
03/31/2009US7511061 Triazoles as farnesyl transferase inhibitors
03/31/2009US7511042 1-[5-(5-tert-Butyl-2-methoxy-3-methylsulfamoyl-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazole-4-carboxylic acid (2,2-dimethyl-propyl)-amide; small molecule cytokine inhibitor; optimized efficacy, pharmacokinetic; antiinflammatory agent, osteoarthritis, asthma, gastrointestinal, respiratory disorder
03/31/2009US7511034 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
03/26/2009WO2009039257A1 Methods for production of 1,2,4-triazol-3-one
03/26/2009WO2009039255A1 Methods for production of 1,2,4-triazol-3-one
03/26/2009WO2009038847A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides
03/26/2009WO2009038784A1 Triazole fused heteroaryl compounds as p38 kinase inhibitors
03/26/2009WO2008094617A3 Crystalline forms of deferasirox
03/26/2009WO2008007211A8 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds
03/26/2009US20090082413 Deuterium-enriched letrozole
03/26/2009US20090082412 Deuterium-enriched deferasirox
03/26/2009US20090079343 Organic electroluminescent device
03/26/2009CA2691031A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides
03/25/2009EP2038262A2 Triazole compounds that modulate hsp90 activity
03/25/2009EP1991514A4 Novel anthracene derivative and organic electronic device using the same
03/25/2009CN101391986A Fluorine triazole ethers derivates and salt with antimicrobial activity, preparation method and medical use
03/25/2009CN101391985A Triazole onium compound with antimicrobial activity, preparation method and medical use
03/24/2009US7507832 Triazole PPAR modulators
03/24/2009US7507757 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
03/19/2009WO2009015446A3 Triazole derivatives as viral replication inhibitors
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 178